Search clinical trials for: Long acting β-blockers

Total 7835 results

National Center for Research Resources (NCRR)
University of Tennessee

Completed

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Mexiletine for Painful Diabetic Neuropathy

Pain | Diabetic Neuropathies | Paresthesia
Kyunghee University Medical Center
Ministry of Health & Welfare, Korea

Unknown

Acupuncture in Persistent Atrial Fibrillation

Persistent Atrial Fibrillation

Korea, Republic of
A.Menarini Asia-Pacific Holdings Pte Ltd

Unknown

A Study of Pharmacokinetics and Safety of Ranolazine PR in Healthy Korean and Caucasian Male Subjects

Healthy Male Individuals

Korea, Republic of
Novo Nordisk A/S

Completed

Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083

Growth Hormone Disorder | Adult Growth Hormone Deficiency

Denmark
University Hospital, Toulouse

Completed

Pain Reduction in Maxillomandibular Surgery Using Maxillary and Mandibular Nerve Blocks (ECHOMAX)

Pain, Post Operative | Regional Anesthesia

France
BG Unfallklinik

Unknown

Chitosan Nerv Tube for Primary Repair of Traumatic Sensory Nerve Lesions of the Hand (CNT)

Traumatic Lesion of Sensory Nerves of the Hand

Germany
Brigham and Women's Hospital
Johns Hopkins University; National Institute on Aging (NIA); Rutgers University

Active, not recruiting

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Dihydropyridine Calcium Channel Blockers Versus Hydrochlorothiazide

Hypertension

United States
Augusta University

Unknown

Study of Amiloride on Vascular Phenotypes in Young Adults With Prehypertension (SAPHA)

Prehypertension

United States
Population Health Research Institute

Not yet recruiting

Single Dose Flecainide for Early Sinus Rhythm Conversion of Perioperative Atrial Fibrillation After Noncardiac Surgery (FLIP-AF)

Atrial Fibrillation | Surgery
UCB Pharma
SCHWARZ BIOSCIENCES GmbH - Part of UCB Group

Completed

A Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Painful Diabetic Neuropathy

Painful Diabetic Neuropathy

Germany
UCB BIOSCIENCES, Inc.

Completed

Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children. (ASPIRE)

Epilepsy

United States, Hungary, Italy, Poland, Ukraine
UCB BIOSCIENCES, Inc.
UCB Biopharma SRL

Completed

A Clinical Study to Investigate the Efficacy and Safety of Lacosamide as an Add on Therapy in Children With Epilepsy With Partial-onset Seizures

Epilepsy

United States, Argentina, Australia, Belgium, Brazil, Bulgaria, China, Colombia, Croatia, Czechia, Estonia, France, Georgia, Greece, Hungary, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Mexico, Moldova, Republic of, Monten... and more
MEDA Pharma GmbH & Co. KG
3M

Terminated

Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial Fibrillation.

Atrial Fibrillation

Belgium, Bulgaria, France, Germany, Netherlands, Romania, Spain
University of South Alabama

Withdrawn

Safety Study of Rufinamide Given as an add-on Therapy to Treat Patients With Seizures

Refractory Partial Seizures

United States
UCB Pharma

Completed

Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.

Fibromyalgia Syndrome

United States
UCB BIOSCIENCES, Inc.

Completed

Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy

Epilepsy

United States
Bial - Portela C S.A.

Completed

Efficacy and Safety of Eslicarbazepine Acetate as Therapy for Patients With Painful Diabetic Neuropathy

Painful Diabetic Neuropathy
Assistance Publique - Hôpitaux de Paris

Completed

Mexiletine and Non Dystrophic Myotonias (MYOMEX)

Myotonia Congenita | Paramyotonia Congenita | Non-dystrophic Myotonias

France
Indiana University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis (STTEPP)

Chronic Pain | Opioid-Related Disorders | Opioid Use Disorder | Opioid Dependence | Chronic Pancreatitis | Hyperalgesia | Chronic Pain Syndrome | ERCP | Pancreatic Surgery | Chronic Abdominal Pain

United States
UCB BIOSCIENCES, Inc.

Completed

An Open-Label Study to Determine Safety , Tolerability, and Efficacy of Oral Lacosamide in Children With Epilepsy

Epilepsy

United States, Belgium, China, France, Germany, Hungary, Italy, Japan, Mexico, Poland, Ukraine
Eisai Inc.

Completed

Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures

Epilepsy

United States
Evan Adelstein, MD
University of Pittsburgh

Withdrawn

Acute Mechanical Response to Anti-arrhythmic Drug Therapy (AAD and CRT)

Arrhythmias

United States
Eisai Limited

Completed

A Placebo-Controlled, Double-Blind Comparative Study of E2080 in Lennox-Gastaut Syndrome Patients (Study E2080-J081-304)

Lennox-Gastaut Syndrome

Japan
UCB Pharma GmbH

Completed

Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy (VICTOS)

Focal Epilepsy With and Without Secondary Generalization

Germany, Austria
University Hospital Schleswig-Holstein

Completed

Lacosamid-i.v.-Register (LCM)

Epilepsy With Partial Onset Seizures With or Without Secondary Generalization

Germany
Wuhan Union Hospital, China

Completed

Pharmacokinetics and Tolerability of Rufinamide in Healthy Chinese Subjects

Seizures
Bial - Portela C S.A.

Completed

Single Dose Crossover Comparative Bioavailability Study of Eslicarbazepine Acetate Versus To-be-marketed Formulation

Epilepsy
UCB Pharma

Completed

To Evaluate the Pharmacokinetics and Safety/Tolerability of Lacosamide in 3 Dosages in Healthy Male Korean Subjects

Epilepsy
Chronic Obstructive Pulmonary Disease Trial Network...

Recruiting

Once Daily Long-Acting Muscarinic Antagonists Administered in the Evening for Prevention of Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization or Death From Any Cause

COPD Exacerbation

Denmark
Mansoura University

Completed

Effect of Long Acting Anticholinergic on Nocturnal Incontinence After Radical Cystectomy and Orthotopic Neobladder

Nocturnal Incontinence
Maastricht University Medical Center
Nutricia Research

Recruiting

Targeted Nutrient Supplement in COPD (NUTRECOVER-trial) (NUTRECOVER)

Pulmonary Disease, Chronic Obstructive

Netherlands
Icahn School of Medicine at Mount Sinai
National Heart, Lung, and Blood Institute (NHLBI); Canadian Institutes of Health... and other collaborators

Completed

Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation

Postoperative Atrial Fibrillation

United States, Canada
Weill Medical College of Cornell University
U.S. Deprescribing Research Network

Recruiting

N-of-1 for Beta-Blockers in Cardiac Amyloidosis

Heart Diseases | Cardiac Amyloidosis

United States
University of Aarhus

Completed

Renal and Systemic Vascular Resistance in Chronic Kidney Disease (CKD) (RenVas)

Hypertension | Vasodilation | Chronic Kidney Insufficiency

Denmark
Yong Seog Oh

Withdrawn

Beta-blocker vs. Ic Antiarrhythmic Drug for PVC

Premature Ventricular Complex

Korea, Republic of
University of Washington

Completed

Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS) (MX-ALS-001)

Sporadic Amyotrophic Lateral Sclerosis

United States
UCB Pharma

Completed

An Open-label Continuation Trial to Assess the Continued Efficacy and Safety of Ascending Doses of Lacosamide in Subjects With Chronic Refractory Neuropathic Pain

Chronic Refractory Neuropathic Pain

Germany
Bial - Portela C S.A.

Completed

Single-dose and Steady-state Pharmacokinetics of BIA 2-093 and Its Metabolites

Epilepsy

Germany
Bial - Portela C S.A.

Completed

Eslicarbazepine Acetate as Add-On Treatment to One Baseline Antiepileptic Drug (ESLADOBA)

Epilepsy

Portugal
UCB BIOSCIENCES GmbH

Completed

Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Single Dose Lacosamide in Subjects With Renal Impairment Compared to Healthy Subjects

Healthy | Renal Impairment

Germany
Sheba Medical Center

Recruiting

Efficacy and Necessity of Time Interval Between Instillation of Two Glaucoma Eye Drops

Glaucoma | Glaucoma; Drugs

Israel
Tehran University of Medical Sciences

Not yet recruiting

Comparison of the Clinical Response of Total Neoadjuvant Treatment of Two Methods of Long-term or Short-term Chemoradiotherapy in Rectal Cancer (TEHRAN)

Locally Advanced Rectal Carcinoma
University of Alabama at Birmingham
National Institutes of Health (NIH)

Completed

Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease (VEMAKD)

Chronic Kidney Disease | Albuminuria

United States
Galenika AD Beograd
Medicinsko društvo za racionalnu terapiju Republike Srbije (MEDRAT)

Completed

Treatment of Resistant Hypertension: Cohort Study (TRYCORT)

Resistant Hypertension

Serbia
Dana-Farber Cancer Institute
GlaxoSmithKline; Gilead Sciences

Active, not recruiting

A Study of Idelalisib (GS1101, CAL101) + Ofatumumab in Previously Untreated CLL/SLL

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
GlaxoSmithKline

Withdrawn

Legend: TRELEGY Real World Chronic Obstructive Pulmonary Disease (COPD) Effectiveness Study (LEGEND)

Pulmonary Disease, Chronic Obstructive

United States
Second Affiliated Hospital, School of Medicine,...
University of California, Los Angeles; Tongji Hospital; Michigan State University and other collaborators

Unknown

Evaluation of the Efficacy and Safety of Lacosamide in Pediatric Patients With Epilepsy

Epilepsy

China
NYU Langone Health

Completed

Diagnostic Value and Safety of Flecainide Infusion Test in Brugada Syndrome

Brugada Syndrome | Arrhythmogenic Right Ventricular Cardiomyopathy

United States
UCB Pharma

Completed

A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis (SP906)

Migraine

United States
UCB Pharma

Completed

Assess Safety and Efficacy of Lacosamide in Patients With Partial Seizures

Epilepsy

France, Poland, United Kingdom, Germany, Spain, Finland, Australia, Russian Federation, Hungary, Lithuania, Sweden, Czechia, Croatia

Search clinical trials for: Long acting β-blockers

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations